Home/Filings/4/A/0001181431-12-041316
4/A//SEC Filing

Roberts Michael J 4/A

Accession 0001181431-12-041316

CIK 0001333763other

Filed

Jul 18, 8:00 PM ET

Accepted

Jul 19, 4:44 PM ET

Size

5.4 KB

Accession

0001181431-12-041316

Insider Transaction Report

Form 4/AAmended
Period: 2012-07-09
Roberts Michael J
VP, Business Development
Transactions
  • Award

    Stock Option (Right to Buy)

    2012-07-09+50,00050,000 total
    Exercise: $1.24Exp: 2022-07-09Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]This Amendment is filed solely to correct the code in column 5 to reflect that this was an acquisition of securities.
  • [F2]Option vests in four equal annual installments beginning on July 9, 2013.

Documents

1 file

Issuer

Chelsea Therapeutics International, Ltd.

CIK 0001333763

Entity typeother

Related Parties

1
  • filerCIK 0001481629

Filing Metadata

Form type
4/A
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 4:44 PM ET
Size
5.4 KB